首页 | 本学科首页   官方微博 | 高级检索  
   检索      

一种来源于脆弱类杆菌的α-半乳糖苷酶的理化性质及其酶解B型红细胞的工艺研究
引用本文:高红伟,李素波,鲍国强,檀英霞,王颖丽,章扬培,季守平,宫锋.一种来源于脆弱类杆菌的α-半乳糖苷酶的理化性质及其酶解B型红细胞的工艺研究[J].中国科学:生命科学,2011,41(10):1030-1036.
作者姓名:高红伟  李素波  鲍国强  檀英霞  王颖丽  章扬培  季守平  宫锋
作者单位:军事医学科学院野战输血研究所, 北京 100850
基金项目:国家自然科学基金(批准号: 30671538)资助项目
摘    要:利用α-半乳糖苷酶去除红细胞表面的B抗原是制备通用O型红细胞的有效方法.本文在克隆表达纯化脆弱类杆菌来源的α-半乳糖苷酶的基础上对其理化性质进行了研究,该酶的分子量为64908Da,等电点在7.12~7.30之间,最适温度为41℃,最适pH为5.6~6.0,其理化性质适合用于B型红细胞的血型改造;为了确定高效、快速、温和的酶解条件,本文对酶解B型红细胞的工艺进行了优化.通过研究缓冲液对酶与红细胞结合的影响,确定了最佳酶解缓冲液为250mmol/L甘氨酸和3mmol/LNaCl,pH6.8;酶解的最适红细胞压积为40%,酶解温度为26℃,酶解时间为1h.利用优化的酶解工艺获得的B-ECORBCs形态及结构功能指标均正常,流式细胞结果证明其B抗原和H抗原标记率与O型红细胞相当,说明制备B-ECORBCs的工艺已成熟.这种工艺具有酶用量少、酶解条件温和、制备过程简单和时间短等优势,具有很好的临床应用前景.

关 键 词:基因重组α-  半乳糖苷酶  脆弱类杆菌  理化性质  血型改造

Properties of a Novel α-galactosidase from B. Fragilis and Its Potential for Human Blood-type B to O Conversion
GAO HongWei,LI SuBo,BAO GuoQiang,TAN YingXia,WANG YingLi,ZHANG YangPei,JI ShouPing,GONG Feng.Properties of a Novel α-galactosidase from B. Fragilis and Its Potential for Human Blood-type B to O Conversion[J].Scientia Sinica Vitae,2011,41(10):1030-1036.
Authors:GAO HongWei  LI SuBo  BAO GuoQiang  TAN YingXia  WANG YingLi  ZHANG YangPei  JI ShouPing  GONG Feng
Institution:Institute of Transfusion Medicine, Academy of Military Medical Sciences, Beijing 100850, China
Abstract:Enzymatic removal of blood group B antigen is an effective method to develop universal red blood cells (RBCs) by α-galactosidase. Here we investigated the physicochemical properties of a novel α-galactosidase from B. Fragilis and the optimization of enzymatic conversion for RBC of blood group B to O. The results showed that α-galactosidase exhibited maximum activity at a broad optimal pH of 5.6-6.0 and an optimum temperature of 41°C. Furthermore, the enzyme was efficient in complete removal of B antigen. The conditions for B to O blood group conversion were 26°C, pH 6.8 (250 mmol/L glycine and 3 mmol/L NaCl) for 1 h. The structure and function indexes of the converted red blood cells showed no significant difference from those of normal RBCs. Consequently, the novel α-galactosidase described here was more suitable for enzymatic conversion for achieving the goal of producing universal RBCs, which would improve the blood supply while enhancing the safety of clinical transfusions.
Keywords:gene recombinant &alpha  -galactosidase   B  Fragilis  physicochemical properties  blood group conversion
本文献已被 维普 等数据库收录!
点击此处可从《中国科学:生命科学》浏览原始摘要信息
点击此处可从《中国科学:生命科学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号